Helical tomotherapy and two types of volumetric modulated arc therapy: dosimetric and clinical comparison for several cancer sites.
Dose comparison
Linac
Radixact™
Tomotherapy
VMAT
Journal
Radiological physics and technology
ISSN: 1865-0341
Titre abrégé: Radiol Phys Technol
Pays: Japan
ID NLM: 101467995
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
12
12
2022
accepted:
24
03
2023
revised:
23
03
2023
medline:
26
5
2023
pubmed:
21
4
2023
entrez:
21
04
2023
Statut:
ppublish
Résumé
Radiotherapy accelerators have undergone continuous technological developments. We investigated the differences between Radixact™ and VMAT treatment plans. Sixty patients were included in this study. Dosimetric comparison between the Radixact™ and VMAT plans was performed for six cancer sites: whole-brain, head and neck, lymphoma, lung, prostate, and rectum. The VMAT plans were generated with two Elekta linear accelerators (Synergy
Identifiants
pubmed: 37084071
doi: 10.1007/s12194-023-00716-3
pii: 10.1007/s12194-023-00716-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
272-283Informations de copyright
© 2023. The Author(s), under exclusive licence to Japanese Society of Radiological Technology and Japan Society of Medical Physics.
Références
Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol. 1999;9(1):108–17.
doi: 10.1016/S1053-4296(99)80058-7
pubmed: 10196402
Myers PA, Mavroidis P, Papanikolaou N, et al. Comparing conformal, arc therapy and helical tomotherapy in craniospinal irradiation planning. J Appl Clin Med Phys. 2014;15(5):4724–41.
doi: 10.1120/jacmp.v15i5.4724
pubmed: 25207562
Renard-Oldrini S, Guinement L, Salleron J, et al. Dosimetric comparison between VMAT and tomotherapy with para-aortic irradiation for cervix carcinoma. Cancer Radiother. 2015;19(8):733–8.
doi: 10.1016/j.canrad.2015.05.031
pubmed: 26547380
Rong Y, Evans J, Xu-Welliver M, et al. Dosimetric evaluation of intensity-modulated radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy. PLoS ONE. 2015;10(4): e0126222.
doi: 10.1371/journal.pone.0126222
pmcid: 4404135
pubmed: 25894615
Stromberger C, Wlodarczyk W, Marnitz S, et al. Simultaneous integrated boost (SIB): RapidArc and tomotherapy plan comparison for unilateral and bilateral neck irradiation. Anticancer Res. 2015;35(5):2991–7.
pubmed: 25964586
Li S, Zhou Q, Shen LF, et al. Dosimetric comparisons of volumetric modulated arc therapy and tomotherapy for early T-stage nasopharyngeal carcinoma. Biomed Res Int. 2018:2653497. https://doi.org/10.1155/2018/2653497 (PMID: 29967769; PMCID: PMC6008744)
Wang YC, Li CC, Chien CR. Effectiveness of tomotherapy vs linear accelerator image-guided intensity-modulated radiotherapy for localized pharyngeal cancer treated with definitive concurrent chemoradiotherapy: a Taiwanese population-based propensity score-matched analysis. Br J Radiol. 2018;91(1086):20170947.
doi: 10.1259/bjr.20170947
pmcid: 6223294
pubmed: 29565652
Wang Q, Qin J, Cao R, et al. Comparison of dosimetric benefits of three precise radiotherapy techniques in nasopharyngeal carcinoma patients using a priority-classified plan optimization model. Front Oncol. 2021;11: 646584.
doi: 10.3389/fonc.2021.646584
pmcid: 8504456
pubmed: 34646757
Pigorsch SU, Kampfer S, Oechsner M, et al. Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study. Radiat Oncol. 2020;15(1):253–63.
doi: 10.1186/s13014-020-01693-2
pmcid: 7607845
pubmed: 33138837
Lu S, Fan H, Hu X, et al. Dosimetric comparison of helical tomotherapy, volume-modulated arc therapy, and fixed-field intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma. Front Oncol. 2021;11: 764946.
doi: 10.3389/fonc.2021.764946
pmcid: 8602559
pubmed: 34804969
Xhaferllari I, El-Sherif O, Gaede S. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy. J Appl Clin Med Phys. 2016;17(5):329–40.
doi: 10.1120/jacmp.v17i5.6291
pmcid: 5874107
pubmed: 27685129
Li S, Yang J, Liu J, et al. Dosimetric comparison of helical tomotherapy and conventional Linac-based X-knife stereotactic body radiation therapy for primary lung cancer or pulmonary metastases. J Thorac Dis. 2018;10(2):999–1006.
doi: 10.21037/jtd.2018.01.64
pmcid: 5864687
pubmed: 29607173
Xu Y, Deng W, Yang S, et al. Dosimetric comparison of the helical tomotherapy, volumetric- modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer. Sci Rep. 2017;17(1):14863.
doi: 10.1038/s41598-017-14629-w
Klunklin P, Manoharn T, Wanwilairat S, et al. Analysis of the planned, delivered dose distributions and quality assurance for helical tomotherapy and volumetric modulated arc therapy in locally advanced non-small cell lung cancer. Rep Pract Oncol Radiother. 2021;26(6):939–47.
doi: 10.5603/RPOR.a2021.0113
pmcid: 8726455
pubmed: 34992866
Serra M, Ametrano G, Borzillo V, et al. Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer. Medicine (Baltimore). 2020;99(50): e23574.
doi: 10.1097/MD.0000000000023574
pubmed: 33327317
Bedford J, Thomas MDR, Smyth G. Beam modeling and VMAT performance with the Agility 160-leaf multileaf collimator. J Appl Clin Med Phys. 2013;14(2):172–85.
doi: 10.1120/jacmp.v14i2.4136
pmcid: 5714360
Fiandra C, Rossi L, Alparone A, et al. Automatic genetic planning for volumetric modulated arc therapy: a large multi-centre validation for prostate cancer. Radiother Oncol. 2020;148:126–32.
doi: 10.1016/j.radonc.2020.04.020
pubmed: 32361572
Hodapp N. The ICRU-Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188(1):97–106.
doi: 10.1007/s00066-011-0015-x
pubmed: 22234506
Riet van’t A, Mak AC, Moerland MA, et al. A conformal number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys. 1997;37:731–6.
doi: 10.1016/S0360-3016(96)00601-3
Wu Q, Mohan R, Morris M, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys. 2003;56(2):573–85.
doi: 10.1016/S0360-3016(02)04617-5
pubmed: 12738335
Ohtakara K, Hayashi S, Hoshi H. Dose Gradient analyses in linac-based intracranial stereotactic radiosurgery using Paddick’s gradient index: consideration of the optimal method for plan evaluation. J Radiat Res. 2011;52(5):592–9.
doi: 10.1269/jrr.11005
pubmed: 21768752
Miften M, Olch A, Mihailidis D, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No 218. Med Phys. 2018;45(4):e53–83.
doi: 10.1002/mp.12810
pubmed: 29443390
Kraus KM, Kampfer S, Wilkens JJ, et al. Helical tomotherapy: comparison of Hi-ART and Radixact clinical patient treatments at the Technical University of Munich. Sci Rep. 2020;10(5):4928–38.
doi: 10.1038/s41598-020-61499-w
pmcid: 7080845
pubmed: 32188899
Fiandra C, Filippi AR, Catuzzo P, et al. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations. Radiat Oncol. 2012;7:186–94.
doi: 10.1186/1748-717X-7-186
pmcid: 3502518
pubmed: 23122028
Levis M, Filippi AR, Fiandra C, et al. Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin’s lymphoma patients. Radiother Oncol. 2019;138:52–8.
doi: 10.1016/j.radonc.2019.05.009
pubmed: 31146071
Filippi AR, Vanoni V, Meduri B, et al. Intensity modulated radiation therapy and second cancer risk in adults. Int J Radiat Oncol Biol Phys. 2018;100(1):17–20.
doi: 10.1016/j.ijrobp.2017.09.039
pubmed: 29254772
Bibault JE, Dussart S, Pommier P, et al. Clinical outcomes of several imrt techniques for patients with head and neck cancer: a propensity score-weighted analysis. Int J Radiat Oncol Biol Phys. 2017;99(4):929–37.
doi: 10.1016/j.ijrobp.2017.06.2456
pubmed: 28864403
Mori M, Cattaneo GM, Dell’Oca I, et al. Skin DVHs predict cutaneous toxicity in Head and Neck Cancer patients treated with Tomotherapy. Phys Med. 2019;59:133–41.
doi: 10.1016/j.ejmp.2019.02.015
pubmed: 30824367